139 related articles for article (PubMed ID: 17624700)
1. Biopharmaceutic evaluation of novel anthelmintic (1H-benzimidazol-5(6)-yl)carboxamide derivatives.
Rivera JC; Yépez-Mulia L; Hernández-Campos A; Moreno-Esparza R; Castillo R; Navarrete-Vázquez G; Fuentes-Noriega I; Jung-Cook H
Int J Pharm; 2007 Oct; 343(1-2):159-65. PubMed ID: 17624700
[TBL] [Abstract][Full Text] [Related]
2. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs.
Daniel-Mwambete K; Torrado S; Cuesta-Bandera C; Ponce-Gordo F; Torrado JJ
Int J Pharm; 2004 Mar; 272(1-2):29-36. PubMed ID: 15019066
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of some novel 2-phenyl benzimidazole-1-acetamide derivatives as potential anthelmintic agents.
Sawant R; Kawade D
Acta Pharm; 2011 Sep; 61(3):353-61. PubMed ID: 21945914
[TBL] [Abstract][Full Text] [Related]
4. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs.
Gokbulut C; Bilgili A; Hanedan B; McKellar QA
Vet Parasitol; 2007 Sep; 148(3-4):279-87. PubMed ID: 17673370
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability comparison between albendazole and albendazole sulphoxide in rats and man.
Dominguez L; Fagiolino P; Gordon S; Manta E
Farmaco; 1995 Oct; 50(10):697-702. PubMed ID: 8590577
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro cysticidal activity of new benzimidazole derivatives.
Palomares-Alonso F; Jung-Cook H; Pérez-Villanueva J; Piliado JC; Rodríguez-Morales S; Palencia-Hernández G; López-Balbiaux N; Hernández-Campos A; Castillo R; Hernández-Luis F
Eur J Med Chem; 2009 Apr; 44(4):1794-800. PubMed ID: 18582991
[TBL] [Abstract][Full Text] [Related]
7. Antihelminthic activity of some newly synthesized 5(6)-(un)substituted-1H-benzimidazol-2-ylthioacetylpiperazine derivatives.
Mavrova ATs; Anichina KK; Vuchev DI; Tsenov JA; Denkova PS; Kondeva MS; Micheva MK
Eur J Med Chem; 2006 Dec; 41(12):1412-20. PubMed ID: 16996654
[TBL] [Abstract][Full Text] [Related]
8. A molecular modeling approach to in vivo efficacy of triclabendazole.
Lipkowitz KB; McCracken RO
J Parasitol; 1991 Dec; 77(6):998-1005. PubMed ID: 1779306
[TBL] [Abstract][Full Text] [Related]
9. Highly water-soluble prodrugs of anthelmintic benzimidazole carbamates: synthesis, pharmacodynamics, and pharmacokinetics.
Chassaing C; Berger M; Heckeroth A; Ilg T; Jaeger M; Kern C; Schmid K; Uphoff M
J Med Chem; 2008 Mar; 51(5):1111-4. PubMed ID: 18271517
[TBL] [Abstract][Full Text] [Related]
10. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
Gokbulut C; Akar F; McKellar QA
Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
[TBL] [Abstract][Full Text] [Related]
11. Transtegumental diffusion of benzimidazole anthelmintics into Moniezia benedeni: correlation with their octanol-water partition coefficients.
Mottier ML; Alvarez LI; Pis MA; Lanusse CE
Exp Parasitol; 2003; 103(1-2):1-7. PubMed ID: 12810040
[TBL] [Abstract][Full Text] [Related]
12. Sensitive chiral high-performance liquid chromatographic determination of anthelmintic flubendazole and its phase I metabolites in blood plasma using UV photodiode-array and fluorescence detection Application to pharmacokinetic studies in sheep.
Nobilis M; Vybíralová Z; Krízová V; Kubícek V; Soukupová M; Lamka J; Szotáková B; Skálová L
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(1):89-96. PubMed ID: 19004671
[TBL] [Abstract][Full Text] [Related]
13. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.
Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C
Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276
[TBL] [Abstract][Full Text] [Related]
14. Effects of formulation concentration on intravenous pharmacokinetics, chirality and in vitro solubility of oxfendazole and its metabolites in sheep.
Sánchez Bruni SF; Jones DG; Small J; McKellar QA
J Vet Pharmacol Ther; 2005 Oct; 28(5):467-73. PubMed ID: 16207310
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs.
Alvarez L; Lifschitz A; Entrocasso C; Manazza J; Mottier L; Borda B; Virkel G; Lanusse C
J Vet Pharmacol Ther; 2008 Jun; 31(3):230-9. PubMed ID: 18471144
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and QSAR evaluation of 2-(substituted phenyl)-1H-benzimidazoles and [2-(substituted phenyl)-benzimidazol-1-yl]-pyridin-3-yl-methanones.
Sharma D; Narasimhan B; Kumar P; Jalbout A
Eur J Med Chem; 2009 Mar; 44(3):1119-27. PubMed ID: 18657885
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep.
Virkel G; Lifschitz A; Sallovitz J; Pis A; Lanusse C
J Vet Pharmacol Ther; 2006 Jun; 29(3):213-23. PubMed ID: 16669866
[TBL] [Abstract][Full Text] [Related]
18. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes.
Alvarez LI; Solana HD; Mottier ML; Virkel GL; Fairweather I; Lanusse CE
Parasitology; 2005 Oct; 131(Pt 4):501-10. PubMed ID: 16174415
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of benzimidazole derivatives].
Spasov AA; Smirnova LA; Iezhitsa IN; Sergeeva SA; Ozerov AA
Vopr Med Khim; 2002; 48(3):233-58. PubMed ID: 12243082
[TBL] [Abstract][Full Text] [Related]
20. Comparative hepatic and extrahepatic enantioselective sulfoxidation of albendazole and fenbendazole in sheep and cattle.
Virkel G; Lifschitz A; Sallovitz J; Pis A; Lanusse C
Drug Metab Dispos; 2004 May; 32(5):536-44. PubMed ID: 15100176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
